Cystic teratoma of the mediastinum: demonstration of fat/fluid level.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A S Fulcher.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Leiomyomatosis peritonealis disseminata (LPD) is a rare disorder usually discovered incidentally in women of child-bearing age and is characterized by multiple subperitoneal smooth muscle nodules. Case reports of two patients with complications related to LPD and a review of the literature are presented. In one case, the patient carried the diagnosis of LPD for 11 years and experienced sarcomatous transformation; this is the first report of the magnetic resonance appearance of this entity. In the second case, LPD was diagnosed after an LPD implant on the ovary-induced ovarian torsion. We also present a patient in whom large, pedunculated uterine leiomyomas mimicked LPD. The clinical presentation, possible pathogenesis, imaging features, and therapeutic options of LPD are reviewed. Because this uncommon condition is being reported with increasing frequency, familiarity with its imaging features and pitfalls is important to suggest the diagnosis in the appropriate clinical setting.
A patient with Kikuchi disease (histiocytic necrotizing lymphadenitis), who came to clinical attention because of cervical lymphadenopathy, is presented. CT and ultrasonographic findings of this disease are described. The importance of this entity lies in the fact that it can be easily confused clinically, pathologically, and radiologically with malignant lymphadenopathy, especially lymphoma.
MR cholangiopancreatography (MRCP) represents a relatively new development in MR technology that provides a noninvasive alternative to endoscopic retrograde cholangiopancreatography for evaluating pancreaticobiliary tract disease. Although the accuracy of MRCP has been documented in the diagnosis of a variety of diseases including choledocholithiasis and malignancy, pitfalls associated with this technique may result in diagnostic errors. This essay illustrates both technical and interpretive pitfalls of MRCP and suggests strategies for their recognition and avoidance.
PURPOSE: The goal of this work was to describe the clinical and imaging features of thoracopancreatic fistula, a rare complication of pancreatitis. METHOD: Nine cases of thoracopancreatic fistula proved by thoracentesis, endoscopic retrograde cholangiopancreatography (ERCP), or surgery were retrospectively and independently reviewed by two abdominal radiologists. All available imaging examinations [chest radiographs = 9, CT = 9, MR and MR cholangiopancreatography (MRCP) = 2, and ERCP = 6] were analyzed, and findings were recorded on a standardized datasheet. Available medical records (n = 7) were reviewed to determine the clinical presentation of the patients and thoracentesis results. RESULTS: Seven of the nine patients presented with pulmonary symptoms such as dyspnea or cough. Of the seven patients with pleural fluid analysis, all demonstrated elevated amylase levels (mean 13,007 U/L). Imaging examinations revealed pancreaticopleural fistulas in six patients, a mediastinal pseudocyst in one patient, and both a pancreaticopleural fistula and a mediastinal pseudocyst in two patients. Chest radiography showed pleural fluid collections in eight patients. CT demonstrated a fluid-containing fistula in all nine patients. MR and MRCP depicted a fistula extending from the abdomen to the pleural space in the two patients with MR correlation. ERCP showed pancreatic ductal changes characteristic of chronic pancreatitis in the six patients with ERCP correlation but failed to demonstrate the fistula in two of the six patients. CONCLUSION: The CT, MR, MRCP, or ERCP finding of a fluid-filled tract extending from the pancreas to the thorax is characteristic of a thoracopancreatic fistula, particularly when identified in a patient who presents with pulmonary symptoms and a history of chronic pancreatitis.
After external-beam radiation therapy, radiation-induced changes may be observed in abdominal and pelvic organs at imaging. In the liver, an area of low attenuation corresponding to the radiation port (or an area of hyperattenuation if the underlying liver tissue shows fatty change) can be seen at computed tomography (CT) performed within 3-6 months after therapy. Later, the liver may be fibrotic and contracted. In the stomach, small intestine, and colon, wall thickening and edema are early manifestations. Ulcers may also be observed. Long-term complications include strictures and fistulas. After irradiation of the kidneys, altered attenuation of the renal parenchyma may be seen at CT. Ureteral strictures, typically involving the distal ureter, may be observed after pelvic irradiation. The bladder may be small and contracted with a thickened wall after radiation exposure. Fistulas between the bladder and other pelvic organs sometimes occur. Typical musculoskeletal changes include growth abnormalities in skeletally immature patients, fatty replacement of bone marrow, and radiation osteitis. Radiation-induced neoplasms are also recognized after therapy.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Magnetic resonance (MR) pancreatography is being used with increasing frequency as a noninvasive alternative to diagnostic endoscopic retrograde pancreatography in the evaluation of the pancreatic duct and various pathologic conditions of the pancreas. This recently developed technique allows improved spatial resolution and permits imaging of the entire pancreatico-biliary tract during a single breath hold. MR pancreatography can help identify the course and drainage pattern of the pancreatic duct and is useful in diagnosing congenital anomalies such as pancreas divisum and annular pancreas without the risk of inducing pancreatitis. In some instances, MR pancreatography may demonstrate duct disruption and associated fluid collections resulting from trauma. In recurrent acute pancreatitis, MR pancreatography is useful in suggesting the cause of the disease; in chronic pancreatitis, it is useful in depicting ductal anatomy, detecting strictures or intraductal calculi prior to surgery, and detecting complications such as pseudocysts and fistulas. In addition, MR pancreatography performed in conjunction with abdominal MR imaging is useful in identifying pancreatic malignancies as well as in establishing resectability and preventing unnecessary preoperative stent placement.
Magnetic resonance (MR) cholangiography is a fast, accurate, noninvasive alternative to endoscopic retrograde cholangiography (ERC) in the evaluation of biliary tract disease. Technical improvements in imaging sequences (eg, half-Fourier rapid acquisition with relaxation enhancement) and use of phased-array coils allow high-quality imaging comparable to that available with ERC. In choledocholithiasis, common bile duct stones as small as 2 mm can be detected with MR cholangiography and appear as low-signal-intensity foci within the high-signal-intensity bile. MR cholangiography may help establish the diagnosis of malignant obstruction and is useful in the evaluation of patients in whom ERC was unsuccessful or incomplete. The role of MR cholangiography in the evaluation of intrahepatic duct disease continues to evolve. MR cholangiography plays a crucial role in evaluating postsurgical biliary tract alterations and can be used to demonstrate a variety of congenital anomalies of the biliary tract (eg, aberrant ducts, choledochal cysts, pancreas divisum). In addition, intentional or incidental imaging of the gallbladder with MR cholangiography can be used to identify calculi or help determine the presence and extent of neoplastic disease.
Living donor liver transplantation is emerging as an alternative to cadaveric liver transplantation. The authors present multimodality images obtained in 44 cases of living donor liver transplantation. The images in this article were derived from the pre-, intra-, and postoperative imaging protocol for their institutional transplantation program. Preoperative magnetic resonance (MR) imaging in the donor allows detection of focal liver lesions and accurate determination of liver volume. The latter is crucial to ensure adequate postoperative liver function for donors and recipients. MR cholangiography depicts donor biliary anatomy. MR angiography and digital subtraction arteriography are performed to assess vascular anatomy. Intraoperative ultrasonography (US) helps determine the resection plane during donor hepatectomy. Postoperative MR imaging documents liver regrowth. MR imaging, US, and computed tomography help assess complications in donors and recipients.
The cystic duct can be depicted with a variety of imaging modalities but is optimally visualized with direct cholangiography or magnetic resonance cholangiopancreatography. Nevertheless, unrecognized anatomic variants of the cystic duct may cause confusion on imaging studies and complicate subsequent surgical, endoscopic, and percutaneous procedures. Primary entities involving the cystic duct include calculous disease, Mirizzi syndrome, cystic duct-duodenal fistula, biliary obstruction, neoplasia, and primary sclerosing cholangitis. The cystic duct may also be secondarily involved by adjacent malignant or inflammatory processes. Postoperative alterations are seen after liver transplantation or cholecystectomy when a portion of the cystic duct is left behind as a remnant. Recognized postoperative complications include retained cystic duct stones, cystic duct leakage, and malposition of T tubes in the remnant. Pitfalls encountered in cystic duct imaging include pseudocalculous defects from overlap of the cystic duct and common bile duct, underfilling of the cystic duct during direct cholangiography, and admixture defects at the cystic duct orifice. Pseudomass or pseudotumor defects may result from an impacted cystic duct stone or from a tortuous, redundant cystic duct. Familiarity with the imaging appearance of the normal cystic duct, its anatomic variants, and related disease processes facilitates accurate diagnosis and helps avoid misinterpretation.